The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?

Serotonin reuptake inhibitors (SRIs) are often prescribed during pregnancy. Previous studies that found an increased risk of congenital anomalies, particularly congenital heart anomalies (CHA), with SRI use during pregnancy have created concern among pregnant women and healthcare professionals about...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Daud, Aizati N. A., Bergman, Jorieke E. H., Kerstjens-Frederikse, Wilhelmina S., Groen, Henk, Wilffert, Bob
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2016
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5000730/
https://ncbi.nlm.nih.gov/pubmed/27529241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17081333
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki